PTSM: Pharmaceutical Technology Sourcing and Management
EAG Laboratories announces new company identity and intent to expand testing, analysis, and characterization capabilities across multiple markets.
EAG Inc., a scientific services company that serves technology- and life-science-related industries, announced on July 12, 2016, that it has combined its 11 brands under EAG Laboratories to bring together capabilities in the materials, engineering, and life sciences sectors. The company reports that it will leverage scientific personnel in 20 locations in the United States, Europe, and Asia-Pacific regions to serve multiple markets.
“Over the last decade, EAG has quietly added capabilities through complementary acquisitions and service line expansions in the high-growth contract research and testing space,” stated Siddhartha Kadia, president and CEO, EAG Laboratories in a press statement. “We’ve built a problem-solving culture in which our scientists and engineers go beyond simply delivering data; they interpret results and find answers that support our clients’ commercial success. That is something today’s technology-driven companies need from their outsourcing partners, and it makes EAG unique in the scientific services arena. By unifying multidisciplinary expertise under one brand, we simplify delivery of our services to enhance our customer relationships.”
EAG Laboratories offers testing, analytical, and characterization services for drug development and other industries including environmental testing, custom synthesis and radiolabeling, crop sciences, materials testing, contaminant identification, failure analysis, engineering services, consulting and expert testimony.
In July 2015, the company acquired Analytical Bio-Chemistry Laboratories (ABC Laboratories), adding US and European testing, analysis, and characterization services including cGMP and GLP-compliant testing capabilities for small- and large-molecule therapies.
In 2011, EAG acquired Chemir Analytical Services, adding analytical services such as stability programs, extractables and leachables testing, bioanalysis, and custom synthesis.
The following brands will be known as EAG Laboratories: Evans Analytical Group, ABC Laboratories, Chemir Analytical Services, SEAL Laboratories, PTRL West, PTRL Europe, Wildlife International, Shiva Technologies, NanoScience, Accurel, and MEFAS.
Source: EAG Laboratories
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space
May 7th 2025The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.